Abstract
Differentiated thyroid cancer (DTC) is frequently found in mid-aged and young women. DTC has been the second common malignancy diagnosed during pregnancy. The clinical therapy of DTC has involvement of both mother’s health and fetal safety and thus is usually difficult. Currently, there are still controversies in the therapy of DTC in pregnant women. Herein we summarize the advance in the surgical therapy, radioactive iodine therapy and thyroid hormone replacement therapy in pregnancy and after delivery and explore more effective strategies which are beneficial for the mother and fetus, which willprovide more evidence for the selection of strategies for the clinical management of DTC in pregnant women.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.